Stage (next event)
Phase 1 Readout
Catalyst Info & Data Links
TITLE: Altimmune AdCOVID (COVID-19 Intranasal Vaccine) Phase 1 readout
WHAT IS THE NEXT CATALYST EVENT?
Phase 1 readout
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
08-12-2020 Company Slide deck (Slides 10-14)
Mechanism of Action
MECHANISM OF ACTION
By utilizing the Company’s proprietary intranasal vaccine technology, it is expected that AdCOVID has the potential to activate multiple arms of the immune system as shown in a recent Phase 2 clinical study with NasoVAX, an influenza vaccine candidate based on the same platform technology. That study showed potent stimulation of mucosal and cellular immune responses in addition to a strong serum antibody response.
Updated by MV
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See what the community is saying - click to see full post